Top 1-Month Price Return US Stocks — Highest Short-Term Momentum on NYSE & NASDAQ

US stocks with 5%+ monthly price return — short-term momentum leaders that are outperforming the market significantly in the current month.

Stocks Found: 100
Updated: Daily
Data Source: StockSifting DB

About This Screen

One-month price return leaders capture the most recent market momentum — stocks generating 5%+ returns in a single month when the market average monthly return is approximately 0.6%. These are the current market leaders, reflecting earnings beats, positive guidance, sector rotation inflows, or institutional accumulation. The short time frame makes this screen both highly actionable and highly volatile.

WHAT THIS SCREEN FINDS: US NYSE and NASDAQ stocks with 5%+ monthly price return, market cap above $500M (institutional quality), and positive net margin (profitable businesses). These are the strongest price performers over the most recent 30-day window — the current market leadership cohort.

1-Month Return % = ((Current Price − Price 30 Days Ago) / Price 30 Days Ago) × 100 | Filter: 1-Month Return > 5% AND Market Cap > $500M AND Net Margin > 0 | Sorted by 1-month return descending

KEY METRICS EXPLAINED: A 5% monthly return represents roughly 60%+ annualized outperformance versus the market's 7-10% annual average. Stocks moving 5%+ in a month typically have a specific catalyst: earnings acceleration, analyst upgrades, new product success, or sector rotation inflow. The market cap and margin filters ensure these are quality businesses in real uptrends, not thin-volume speculative moves.

WHY INVESTORS USE IT: Short-term momentum leaders often continue to outperform in the near term as institutional investors who missed the initial move add exposure. Earnings beat catalysts produce months of continued positive revisions and fund inflows. The 1-month return screen identifies where institutional money is flowing right now — useful context for sector allocation and near-term trading decisions.

BENEFITS: Real-time market leadership indicator. Captures post-earnings momentum when stocks tend to continue outperforming. Identifies sector rotation trends as they're happening, not after the fact. Useful for swing traders and short-term momentum investors. When combined with fundamental quality filters, identifies the best businesses currently receiving market attention.

RISKS AND LIMITATIONS: Short-term momentum has much higher reversal risk than 12-month momentum. Stocks up 15%+ in a month may be candidates for mean reversion as short-term traders take profits. Post-earnings moves can reverse if subsequent quarters disappoint. This screen works best as a monitoring tool combined with fundamental analysis, not as a standalone entry signal.

HOW TO ANALYZE STOCKS FROM THIS SCREEN: Identify the catalyst for the monthly move — was it earnings, a product announcement, an analyst upgrade, or sector rotation? Earnings-driven moves with positive guidance revisions are more durable than sentiment-driven moves. Check the valuation: is the stock now expensive post-move? Review the year-long chart to understand whether the current month's move is part of a longer trend or a breakout from consolidation.

COMMON MISTAKES: Chasing 1-month leaders purely on price performance without understanding the catalyst. Buying after the stock has already moved significantly, increasing the reversal risk. Ignoring valuation expansion — a stock that moved from P/E 15 to P/E 25 in one month has significantly higher valuation risk. Not monitoring position closely for reversal signals in short-term momentum trades.

Related screens: Top 1-Year Price Return (medium-term momentum confirmation), All-Time High Momentum (structural trend backing), Minervini Trend Template (Stage 2 prerequisite), CANSLIM Growth (earnings momentum confirmation), Darvas Box Scan (momentum with price structure).

Frequently Asked Questions

What does 1-month price return measure?

One-month price return = (Current Price − Price 30 Days Ago) / Price 30 Days Ago × 100. It measures total price appreciation over the most recent calendar month. A 5% monthly return means the stock has outperformed the typical market month (roughly 0.6% average) by approximately 8–9 times — a clear signal of concentrated buying and positive momentum.

What causes a stock to return 5%+ in a single month?

Most commonly: strong quarterly earnings beat with positive forward guidance, analyst upgrades with raised price targets, new product announcements, sector rotation inflows (when investors rotate into a sector, leading stocks can move quickly), M&A speculation, and index inclusion announcements. The catalyst matters enormously for assessing whether the move will continue.

Is 1-month momentum more or less reliable than 12-month momentum?

Less reliable. Academic research shows 12-month momentum has strong persistence over the following 6–12 months. One-month momentum has much higher reversal risk — very short-term moves are more susceptible to profit-taking, mean reversion, and noise. The 1-month screen is useful for identifying current market activity but requires more careful catalyst analysis than the 12-month screen.

How does a 5% monthly return compare to market averages?

The US stock market has historically averaged approximately 7–10% per year, or roughly 0.6–0.8% per month. A stock returning 5% in a single month is outperforming the monthly market average by approximately 6–8 times. This level of outperformance almost always has a specific driver worth identifying before evaluating the stock further.

Can the 1-month screen be used to identify sector trends?

Yes. If multiple stocks in the same sector appear on the 1-month screen simultaneously, it signals a sector rotation or sector-specific catalyst is driving broad buying. Sector rotation trends identified early can inform portfolio allocation decisions — a sector where 10+ companies are moving 5%+ in the same month is receiving significant institutional attention.

What is the risk of buying stocks near the top of a 1-month move?

Significant. A stock that has already moved 15%+ in a month has already attracted significant attention and potentially exhausted near-term buyers. Mean reversion risk is highest immediately after large single-month moves as short-term traders sell to lock in gains. Buying into strength requires clear evidence of a continuing fundamental catalyst, not just the price move itself.

Should I use stop-losses with 1-month momentum stocks?

Yes, and tighter than with value positions. Short-term momentum can reverse rapidly. A stop-loss of 5–8% below entry is reasonable for momentum trades. Some practitioners use a trailing stop — if the stock gives back more than half its 1-month gain, exit. The key is defining the exit before entry, not after the position moves against you.

How does this screen differ from the 1-year return screen?

The 1-year screen identifies established medium-term momentum leaders with a full 12 months of outperformance. The 1-month screen captures the newest momentum — stocks just beginning a potential move or stocks that had a specific catalyst this month. The 1-year screen is for systematic momentum investing; the 1-month screen is more for tactical and near-term market activity monitoring.

Which time of the year produces the most 1-month leaders?

Earnings seasons (January, April, July, October) produce the most concentrated 1-month momentum as companies report results and many stocks gap up on beats. These months see the most dramatic monthly performers. The period between earnings seasons typically produces fewer extreme monthly movers except when macro data or Fed announcements drive broad sector moves.

Can small-cap stocks appear on this screen?

The market cap minimum of $500M filters out most small-caps. This is intentional — in stocks below $500M, 5% monthly moves can occur from minimal volume and don't necessarily reflect genuine institutional buying. Above $500M, a 5% monthly move requires meaningful dollar volume and confirms real institutional participation rather than thin-market volatility.

Results 100 stocks matched

Refreshed daily · Sorted by Market Cap (High → Low)

✓ Live Data
S.No. Company 1-Month Return % Price P/E Mkt Cap Div Yld % ROCE % ROE % 52W High 52W Low
1. Chord Energy Corporation 30990.71% $134.79 175.63 $7.59 B 3.71% 1.62% -0.83% $151.95 $84.25
2. eXp World Holdings Inc 5733.53% $4.75 $856.95 M 2.97% -8.84% -10% $12.23 $4.5
3. Osisko Development Corp. 3620% $2.47 $817.37 M -5.76% -10.6% $6.63 $2.67
4. TechCreate Group Ltd. 3223.85% $172.84 $2.74 B -55.56% -9.63% $355 $3.95
5. Osisko Development Corp. 2660% $2.47 $817.37 M -5.76% -10.6% $6.63 $2.67
6. Sharplink, Inc. 2267.28% $5.19 $1.02 B -1.35% -73.93% $59.02 $5.06
7. QMMM Holdings Limited 2152.83% $119.4 $872.34 M -29.6% -29.89% $303 $0.85
8. GameStop Corp. 1625.05% $21.8 23.71 $9.92 B 2.94% 8% $30.61 $19.93
9. Osisko Development Corp. 1566.67% $2.47 $817.37 M -5.76% -10.6% $6.63 $2.67
10. InvenTrust Properties Corp. 1455.12% $33.45 23.76 $2.61 B 2.89% 1.89% 6.1% $33.79 $26.52
11. SEALSQ Corp 1381.93% $3.2 $736.87 M -20.95% -18.7% $8.71 $1.99
12. Regencell Bioscience Holdings Limited 1361.67% $19.99 $1.4 B -57.45% -61.9% $83.6 $9.39
13. Tron Inc. 1247.83% $1.75 169.95 $928.55 M -1.19% 2.69% $12.8 $0.56
14. HIVE Digital Technologies Ltd. 1225% $3.77 $1.62 B -14.16% -13.12% $10.96 $2.22
15. SS Innovations International, Inc. 1150% $3.78 $756.5 M -17.08% -23% $11.87 $3.02
16. Strive Asset Management, LLC 1092.18% $13.92 $1.02 B -91.13% -104.59% $252 $7.02
17. Definium Therapeutics, Inc. 1020% $23.55 $2.57 B -44.54% -102.48% $26.25 $6.34
18. Unusual Machines, Inc. 901.6% $26.7 $1.54 B -13.97% -3.4% $34.36 $6.12
19. Eastman Kodak Company 879.82% $9.06 $907.68 M 0.44% -9.49% -18.29% $14.87 $4.94
20. Serve Robotics Inc. 798.46% $7.75 $651.1 M -31.81% -47.31% $18.64 $7.66
21. Lightwave Logic, Inc. 740.12% $10.14 $1.88 B -26.95% -37.55% $18.71 $0.99
22. Vor Biopharma Inc. 710% $13.16 $728.26 M -84.67% -142.13% $65.8 $3.63
23. Osisko Development Corp. 700% $2.47 $817.37 M -5.76% -10.6% $6.63 $2.67
24. Quantum Computing Inc. 650% $9.96 $2.25 B 0.01% -3.18% -3.55% $25.84 $6.18
25. Hycroft Mining Holding Corporation 641.94% $26.43 $2.41 B -17.49% -40.49% $58.73 $2.93
26. Regencell Bioscience Holdings Limited 593.04% $19.99 $1.4 B -57.45% -61.9% $83.6 $9.39
27. Trump Media & Technology Group Corp. 580.9% $8.27 $2.29 B -10.29% -58.24% $21.83 $7.86
28. Quantum Computing Inc. 566.67% $9.96 $2.25 B 0.01% -3.18% -3.55% $25.84 $6.18
29. Quantum Computing Inc. 530.36% $9.96 $2.25 B 0.01% -3.18% -3.55% $25.84 $6.18
30. Chaince Digital Holdings Inc. 526.55% $5.33 $517.18 M -8.19% -16.06% $36.77 $1.38
31. Enlight Renewable Energy Ltd 525.77% $90.98 209.99 $37.59 B 3.25% 3.63% $31,750 $6,607
32. AMC Entertainment Holdings, Inc. 525.47% $1.79 $1.2 B 0.65% -11.87% $3.6 $0.93
33. Soleno Therapeutics, Inc. 503.48% $53.01 28.77 $2.76 B 2.98% 22.86% $90.32 $29.43
34. Metalla Royalty & Streaming Ltd. 500% $7.02 $991.43 M 0% -1.76% -1.35% $12.54 $4.58
35. Pagaya Technologies Ltd. 493.78% $14.56 13.05 $1.28 B 15.82% 19.85% $44.99 $10.4
36. Digi Power X Inc. 490.91% $6.04 $790.05 M -73.47% -41.88% $9.5 $1.65
37. Keurig Dr Pepper Inc. 489.79% $30.53 22.67 $41.54 B 3.06% 7.74% 6.95% $35.94 $24.88
38. Cogent Biosciences, Inc. 484.78% $31.02 $5.6 B -38.16% -83.29% $43.73 $5.49
39. Capricor Therapeutics, Inc. 483.33% $26.71 $1.59 B -33.78% -59.27% $40.37 $4.3
40. Janux Therapeutics, Inc. 465.19% $13.36 $839.14 M -16.15% -11.85% $35.34 $12.12
41. American Battery Technology Company 449.02% $3.11 $506.1 M -59.36% -63.85% $11.49 $1.2
42. Capricor Therapeutics, Inc. 439.44% $26.71 $1.59 B -33.78% -59.27% $40.37 $4.3
43. Digi Power X Inc. 438.89% $6.04 $790.05 M -73.47% -41.88% $9.5 $1.65
44. Pharvaris N.V. 433.18% $31.09 $2.49 B -54.28% -67.14% $33.33 $15.91
45. Summit Therapeutics Inc. 431.25% $14.77 $11.46 B -161.37% -291.24% $30.98 $13.83
46. FuelCell Energy, Inc. 410% $17.33 $924.94 M 0.35% -14.03% -26.42% $27.69 $3.78
47. Rigetti Computing, Inc. 400.33% $20.68 $6.87 B -12.94% -43.94% $58.15 $10.3
48. Astrana Health, Inc. 400% $37.99 62.31 $1.88 B 0.13% 4.9% 3.88% $39.93 $18.08
49. Avalo Therapeutics, Inc. 393.2% $13.1 $681.51 M -70.45% -77.76% $24.27 $4.06
50. Celldex Therapeutics, Inc. 386.89% $28.62 $2.25 B -54.02% -50.72% $35.79 $19.25
51. BigBear.ai Holdings, Inc. 385.16% $4.2 $2.28 B -11.76% -50.67% $9.39 $3.01
52. Taysha Gene Therapies, Inc. 375.48% $5.5 $1.69 B -34.88% -56.07% $7.3 $2.25
53. Soleno Therapeutics, Inc. 373.68% $53.01 28.77 $2.76 B 2.98% 22.86% $90.32 $29.43
54. Definium Therapeutics, Inc. 370% $23.55 $2.57 B -44.54% -102.48% $26.25 $6.34
55. ProKidney Corp. 367.91% $1.8 $543.71 M -54.13% -28.1% $7.13 $0.54
56. QXO, Inc. 364.95% $15.76 $11.41 B 1.39% -1.71% -5.2% $27.61 $15.45
57. Permian Resources Corporation 348.67% $19.17 24.8 $16.11 B 3.17% 11.46% 6.32% $22.68 $11.92
58. Kenon Holdings Ltd. 348.56% $75.1 50.99 $4.14 B 0.04% 1.24% 5.44% $95.93 $34.52
59. SoundHound AI, Inc. 346.99% $7.39 $3.2 B -30.24% -40.15% $22.17 $5.83
60. Candel Therapeutics, Inc. 346.2% $8.51 $679.22 M -41.46% -60.42% $9.57 $4.35
61. Antero Resources Corporation 319.72% $35.56 11.95 $11.49 B 7.07% 12.71% $45.75 $29.1
62. Quantum Computing Inc. 316.67% $9.96 $2.25 B 0.01% -3.18% -3.55% $25.84 $6.18
63. Capricor Therapeutics, Inc. 315.38% $26.71 $1.59 B -33.78% -59.27% $40.37 $4.3
64. Madrigal Pharmaceuticals, Inc. 313.99% $486.98 $11.23 B -31.61% -50.15% $615 $271.96
65. Gyre Therapeutics, Inc. 310.82% $6.29 119.4 $608.64 M 7.77% -6.34% $9.42 $5.44
66. MaxLinear, Inc. 306.84% $80.92 $7.28 B -16.77% -28.42% $106.28 $11.63
67. Kinetik Holdings Inc. 305.39% $45.19 44.31 $7.55 B 7.08% 2.48% -8.71% $51.51 $31.33
68. Anbio Biotechnology 302.29% $22.99 324.28 $3.82 B 11.61% 35.36% $55.65 $7.92
69. Quantum Computing Inc. 300% $9.96 $2.25 B 0.01% -3.18% -3.55% $25.84 $6.18
70. QuantumScape Corporation 298.31% $7.67 $4.72 B -37.91% -37.3% $19.07 $3.94
71. Root, Inc. 296.42% $53.54 14.17 $833.1 M 15% $162.99 $40.91
72. eXp World Holdings Inc 296.04% $4.75 $856.95 M 2.97% -8.84% -10% $12.23 $4.5
73. Twenty One Capital, Inc. 292.27% $5.64 $4.18 B -69.16% $47.8 $5.61
74. Phillips Edison & Company, Inc. 287.28% $40.31 48.46 $5.59 B 3.32% 3.96% 5.05% $41.07 $32.84
75. Red Cat Holdings, Inc. 284.64% $12.68 $1.93 B -25.73% -36.24% $18.78 $5.77
76. Destiny Tech100 Inc. 282.39% $41.79 20.73 $917.04 M 17.23% $72.87 $19.71
77. Xanadu Quantum Technologies Limited 279.9% $12.9 -45.43% -1.26% $57 $9.75
78. Praxis Precision Medicines, Inc. 275.02% $254 $7.38 B -37.15% -58.74% $366.52 $37.19
79. Regencell Bioscience Holdings Limited 274.59% $19.99 $1.4 B -57.45% -61.9% $83.6 $9.39
80. AST SpaceMobile, Inc. 274.43% $93.6 $36.33 B -5.92% -32.33% $133.86 $25.4
81. EyePoint, Inc. 269.76% $11.78 $987.65 M -74.45% -110.54% $19.11 $7.94
82. New Era Energy & Digital, Inc. 269.48% $4.85 $609.77 M -128.12% -128.26% $9.45 $0.32
83. FuelCell Energy, Inc. 269.12% $17.33 $924.94 M 0.35% -14.03% -26.42% $27.69 $3.78
84. Metalla Royalty & Streaming Ltd. 266.66% $7.02 $991.43 M 0% -1.76% -1.35% $12.54 $4.58
85. Richtech Robotics Inc. 264.86% $2.4 $610.42 M -6.64% -10.68% $7.43 $1.71
86. Viridian Therapeutics, Inc. 264.58% $15.78 $1.81 B -43.85% -60.7% $34.29 $13.18
87. Quantum Computing Inc. 263.64% $9.96 $2.25 B 0.01% -3.18% -3.55% $25.84 $6.18
88. uniQure N.V. 257.44% $26.45 $2.02 B -24.65% -88.99% $71.5 $8.73
89. CytomX Therapeutics, Inc. 256.18% $3 $652.02 M -21.31% -36.61% $8.21 $1.72
90. Altimmune, Inc. 256.01% $2.71 $523.14 M -35.67% -42.57% $7.73 $2.56
91. Savara Inc. 255.56% $5.09 $1.04 B -52.68% -87.19% $7 $1.98
92. Scholar Rock Holding Corporation 255.06% $44.3 $5.31 B -110.26% -162.89% $52.19 $27.07
93. agilon health, inc. 253.35% $96.85 $1.59 B -219.27% -138.61% $98.53 $7.48
94. Alto Neuroscience, Inc. 252.99% $18.26 $702.93 M -38.28% -47.22% $28.44 $2.15
95. Chaince Digital Holdings Inc. 251.65% $5.33 $517.18 M -8.19% -16.06% $36.77 $1.38
96. Iovance Biotherapeutics, Inc. 250% $4.23 $1.91 B -51.39% -50.17% $5.63 $1.66
97. HIVE Digital Technologies Ltd. 250% $3.77 $1.62 B -14.16% -13.12% $10.96 $2.22
98. Gyre Therapeutics, Inc. 249.48% $6.29 119.4 $608.64 M 7.77% -6.34% $9.42 $5.44
99. Novavax, Inc. 247.11% $9.49 3.52 $1.66 B 76.84% 283.08% $11.97 $6.13
100. Spyre Therapeutics, Inc. 246.92% $73.65 $6.4 B -30.53% -31.25% $79.54 $13.93